Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Reading
Algaba F, Epstein JI, Aldape HC, et al. Assessment of prostate carcinoma in core needle biopsy: definition of minimal criteria for the diagnosis of cancer in biopsy material. Cancer. 1996; 78: 376–381.
Armas OA, Aprikian AG, Melamed J, et al. Clinical and pathobiological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adenocarcinoma. Am J Surg Pathol. 1994; 18: 979–991.
Bock BJ, Bostwick DG. Does prostatic ductal adenocarcinoma exist? Am J Surg Pathol. 1999; 23: 781–785.
Bostwick DG. Gleason grading of needle biopsies: correlation with grade in 316 matched prostatectomies. Am J Surg Pathol. 1994; 18: 796–803.
Bostwick DG. Prospective origins of prostate carcinoma: prostatic intraepithelial neoplasia and atypical adenomatous neoplasia. Cancer. 1996; 78: 330–336.
Bostwick DG. Staging prostate cancer-1997: current methods and limitations. Eur Urol. 1997; 32 (suppl): 2–14.
Bostwick DG. Evaluating prostate needle biopsy: therapeutic and prognostic importance. Ca Cancer J Clin. 1997; 47: 297–319.
Bostwick DG, Algaba F, Amin MB, et al. Consensus statement on terminology: recommendation to use atypical adenomatous hyperplasia in place of adenosis of the prostate. Am J Surg Pathol. 1994; 18: 1069–1070.
Bostwick DG, Pacelli A, Lopez-Beltran A. Molecular biology of prostatic intraepithelial neoplasia. The Prostate. 1996; 29: 117–134.
Bostwick DG, Qian J. Atypical adenomatous hyperplasia of the prostate: relationship with carcinoma in 217 whole-mount radical prostatectomies. Am J Surg Pathol. 1995; 19: 506–518.
Cheng L, Bergstralh E, Cheville JC, et al. Cancer volume of lymph node metastases predicts progression in prostate cancer. Am J Surg Pathol. 1998; 22: 1491–1500.
Cheng L, Bergstralh EJ, Schere BG, et al. Predictors of cancer progression in T1a prostate adenocarcinoma. Cancer. 1999; 85: 1300–1304.
Cheng L, Cheville JC, Bostwick DG. Diagnosis of prostate cancer in needle biopsies after radiation therapy. Am J Surg Pathol. 1999; 23: 1173–1183.
Cheng L, Slezak J, Bergstralh EJ, et al. Preoperative prediction of surgical margin status in prostate cancer patients treated by radical prostectomy. J Clin Oncol. 18: 2862–8, 2000.
Cheng L, Zincke H, Blute ML, et al. Risk of prostate cancer death in patients with lymph node metastasis. Cancer. 91: 66–75, 2001.
Cheville JC, Bostwick DG. Post-atrophic hyperplasia of the prostate: a histologic mimic of prostatic adenocarcinoma. Am J Surg Pathol. 1995; 19: 1068–1076.
Cheville JC, Dundore PA, Bostwick DG, et al. Transitional cell carcinoma of the prostate: clinicopathologic study of 50 cases. Cancer. 1998; 82: 703–707.
Cheville JC, Reznicek MJ, Bostwick DG. The focus of “atypical glands, suspicious for malignancy” in prostatic needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. Am J Clin Pathol. 1997; 108: 633–640.
Devaraj LT, Bostwick DG. Atypical basal cell hyperplasia of the prostate: immunophenotypic profile and proposed classification of basal cell proliferations. Am J Surg Pathol. 1993; 17: 645–659.
Dundore PA, Cheville JC, Nascimento AG, et al. Carcinosarcoma of the prostate: report of 21 cases. Cancer. 1995; 76: 1035–1042.
Egan AJM, Bostwick DG. Prediction of extraprostaticc extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis. Am J Surg Pathol. 1997; 21: 1496–1450.
Egan AJM, Lopez-Beltran A, Bostwick DG. Prostatic adenocarcinoma with atrophic features: malignancy mimicking a benign process. Am J Surg Pathol. 1997; 21: 931–935.
Epstein JI. Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy. Hum Pathol. 1995; 26: 223–229.
Grignon DJ, Sakr WA. Histologic effects of radiation therapy and total androgen blockade on prostate cancer. Cancer. 1995;75:1837–1841.
Henson DE, Hutter RV, Farrow G. Practice protocol for the examination of specimens removed from patients with prostate cancer: a publication of the Cancer Committee, College of American Pathologist. Arch Pathol Lab Med. 1994; 118: 779.
Ickowski KA, Bostwick DG. Minimal criteria for diagnosis of prostate cancer on needle biopsy. Ann Diagn Pathol. 1997; 1 104–129.
Ickowski KA, MacLennan GT, Bostwick DG. Atypical small acinar proliferations of the prostate suspicious for malignancy in needle biopsies: histologic features and clinical significance in 33 cases. Am J Surg Pathol. 1997; 21: 1489–95.
Issacs JT. Molecular markers for prostate cancer metastases: developing diagnostic methods for predicting aggressiveness of prostate cancer. Am J Pathol. 1997; 150: 1511–1521.
Vaillancourt L, Tetu B, Fradet Y, et al. Effect of neoadjuvant endocrine therapy (combined androgen blockage) on normal prostate and prostatic carcinoma: a randomized study. Am J Surg Pathol. 1996; 20: 86–93.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bostwick, D.G., Cheng, L. (2002). Prostate. In: Cheng, L., Bostwick, D.G. (eds) Essentials of Anatomic Pathology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-162-6_22
Download citation
DOI: https://doi.org/10.1007/978-1-59259-162-6_22
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-58829-118-9
Online ISBN: 978-1-59259-162-6
eBook Packages: Springer Book Archive